Quince Therapeutics, Inc. (QNCX) Operating cash flow 2018–2025
Quince Therapeutics, Inc. (QNCX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$41.4MFY2025 · since FY2018: -$11.7M → -$41.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$41.4M | -29.8% |
| FY2024 | -$31.9M | -74.4% |
| FY2023 | -$18.3M | +58.5% |
| FY2022 | -$44.0M | +30.0% |
| FY2021 | -$62.9M | -23.8% |
| FY2020 | -$50.8M | -52.7% |
| FY2019 | -$33.3M | -184.5% |
| FY2018 | -$11.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice